decreased hematocrit_Itgb3<tm1Mgin>/Itgb3<tm1Mgin>

http://metadb.riken.jp/0000208I129S1Sv129X1SvJC57BL6JFVBNItgb3tm1MginItgb3tm1MginItgb3tm1Mgin

decreased hematocrit_Itgb3<tm1Mgin>/Itgb3<tm1Mgin>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• integrin beta 3
  http://metadb.riken.jp/db/mgi_rdf/MGI:96612

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Itgb3<tm1Mgin>/Itgb3<tm1Mgin>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Itgb3<tm1Mgin>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased hematocrit
  http://purl.obolibrary.org/obo/MP_0000208

文献

http://purl.org/net/cito/citesAsAuthority

• Brian G. Petrich, et.al., The antithrombotic potential of selective blockade of talin-dependent integrin alpha IIb beta 3 (platelet GPIIb-IIIa) activation., The Journal of clinical investigation, 2007, 117
  http://rdf.ncbi.nlm.nih.gov/pubmed/17627302